Xanthomonas maltophilia is an important nosocomial pathogen which is isolated from a wide variety of clinical sources, including blood, the respiratory tract, urine, wounds, and spinal fluid, and from environmental sources such as hospital water supplies, faucets, sink drains, respirators, and disinfectant solutions (3-5, 7, 9, 14, 17, 19, 21, 23) . X. maltophilia is also associated with malignant lesions (16) . The rate of isolation is increasing (14, 15) , and it is often resistant to antimicrobial agents that are commonly used initially to treat gram-negative infections (2, 6, 13, 14, 18, 22, 23) .
This study continues the work begun by Hugh and Ryschenkow (10), in which they described 15 serotypes of X. maltophilia on the basis of somatic antigens. These 15 serotypes were among those detected in 26 strains of X. maltophilia. We used the antisera that were produced by Hugh and Ryschenkow (10) and prepared 11 additional antisera to new O antigens. The purpose of this study was to develop a serological typing scheme for X. maltophilia that could be used in the future as an epidemiological typing screen. We present here the results of serologic reactions of 275 clinical and environmental isolates of X. maltophilia.
MATERIALS AND METHODS
Cultures. Two hundred seventy-five strains of X. maltophilia were obtained from diverse geographical areas of the United States. Of these strains, 211 were from human and 16 were from environmental sources; the sources of 48 strains were not known. The immunizing strains used by Hugh and Ryschenkow (10) were from the culture collection of one of us (R.H.). Strains were stored at -70°C in defibrinated rabbit blood. Identification of the isolates was confirmed by using conventional methods (1) .
Preparation of antigens. Immunizing antigens for the production of O antisera were prepared as described previously (10) (12, 000 x g ), the antiserum was filter sterilized by using a 0.22-p.m-pore-size membrane filter and then tested by slide agglutination with the homologous and adsorbing strain(s). (Table 1) were used to type 275 isolates of X. maltophilia. Six of the antisera were included in the study by Hugh and Ryschenkow (10) , and 20 were prepared in this study. Twelve of the antisera exhibited a cross-reaction with one or more of the heterologous immunizing strains and were adsorbed to remove the crossreacting factors. Designations of the antisera, immunizing strains, and adsorbing strains are listed in Table 1 . The titers of the antisera in this study ranged from 8 to 64 by using the slide agglutination test. The titers of antisera prepared by R. Hugh in 1961 (10) were comparable to the titers of antisera prepared in this study. By using adjuvants or changing the immunization schedule, future studies are planned to reduce the number of cross-reactions and to increase titers. An unfortunate consequence of increased titers of antisera reported by some investigators is a corresponding increase in the number of cross-reactions (11, 12) .
Strains 609 and 229 agglutinated in antiserum 609 (10) . We produced an antiserum to strain 229 (serotype 5) and were not able to detect cross-reactivity between these strains. We therefore believe that 229 and 609 were shown to be distinct serotypes by the slide agglutination technique. We postulate that perhaps in some manner the antigenic structure of strain 229 has changed.
The results of slide agglutination of 275 X. maltophilia strains from human and environmental sources are presented in Table 2 . Overall, 259 (94.2%) of the strains could be typed. Nine (3.3%) strains did not agglutinate in the 26 antisera when tested a minimum ofthree times. Three (1.1%) strains isolated from the same institution could not be typed because they autoagglutinated. Two of them were from solutions for injection and one was from an adrenal cortex. Four (1.5%) cultures agglutinated in two or more antisera (polyagglutination). Of the 259 typeable strains, 163 (62.9%) agglutinated in one of the antigenic types described by Hugh and Ryschenkow (10) , and the remaining 96 (37.1%) were typeable with the new antisera.
One hundred thirty-seven (49.8%) of the X. mnaltophilia strains agglutinated in antisera PM-56 (serotype 3), 558 (serotype 10), and 609 (serotype 19). Serotype 3 was most frequently encountered and included 57 (20.7%) strains, over half of which were isolated from blood. Thirty of the serotype 3 strains were isolated during an epidemiological investigation of pyrogenic reactions in a hemodialysis unit. No isolates representing serotypes 1 (873-3), 11 (294), or 25 (PM-219) were found among the 275 X. maltophilia strains examined.
The reproducibility of agglutination reactions was 100% on at least two different dates (data not shown), with intervals between repeat agglutination reactions ranging from 2 weeks to over 1 year.
This typing set of 26 antisera was primarily intended to serve as a screen to differentiate between strains of X. maltophilia. Its value as an epidemiological tool needs to be determined by further application to strains from outbreaks. With more sophisticated techniques such as rRNA typing (8) or isoenzyme electrophoretic typing (20) , the subdivision of strains within serotypes could be possible. Our future plans include the study of additional strains and identification of new serotypes of X. maltophilia.
